Document is current
Any future updates will be listed below
-
Authors
Venugopal, Sangeetha
Mascarenhas, John http://orcid.org/0000-0002-8400-0483
- License Information
-
More Information
Article History
Received: 14 October 2020
Accepted: 9 November 2020
First Online: 2 December 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: John Mascarenhas has received research funding paid to the institution from Incyte, Roche, CTI Biopharma, Novartis, Promedior, Merck, Janssen, Arog, Merus, and Pharma Essentia, Kartos, Forbius; consulting fees from Geron, Constellation, Prelude, Galecto, Promedior, and Celgene/BMS, Kartos. Sangeetha Venugopal has nothing to disclose.
